论文部分内容阅读
当前,全球公认乙型病毒性肝炎(下称乙肝)是一种可防性,但无特效药可治愈的急、慢性传染病,是严重危害人们身体健康的公共卫生问题。为了挽救下一代人深受其害,卫生部在1992年将乙肝免疫(HBV)接种纳入儿童计划免疫规范管理。并于 1997年下发“基因工程乙肝疫苗取代血源乙肝疫苗的57号文件”,然而要如何将有价疫苗接种落到实处是免疫成功与失败的焦点,笔者将参加福建省1999年全国儿童计划免疫与HBV接种率及影响因素调查的福州市辖部分即7个选定点和日常工作碰到的问题给予总结,报告如下:1 内容与方法
At present, it is universally recognized that hepatitis B virus (hereinafter referred to as hepatitis B) is a preventable but non-cure curable acute and chronic infectious disease, which is a public health problem that seriously endangers people’s health. In order to save the next generation from being harmed, the Ministry of Health incorporated hepatitis B immunization (HBV) vaccination into the immunization of children’s programs in 1992. And in 1997 issued a “genetically engineered Hepatitis B vaccine to replace Hepatitis B Vaccine No. 57,” but how to conduct valuable vaccinations in real-time is the focus of the success and failure of immunization, the author will participate in the 1999 Fujian Province children Plan immunization and HBV vaccination rates and influencing factors survey Fuzhou part of the seven selected points and daily work encountered problems are summarized as follows: 1 content and methods